Medigen Vaccine Biologics Corp.TPEX: 6547

Announcement of the Company's full receipt of cash capital increase in 2022 and the reference date of capital increase

· Issued by Medigen Vaccine Biologics Corp.
Close
Today's Information

Provided by: Medigen Vaccine Biologics Corporation
SEQ_NO 1 Date of announcement 2022/07/01 Time of announcement 14:48:06
Subject
 Announcement of the Company's full receipt of
cash capital increase in 2022 and the reference date of
capital increase
Date of events 2022/07/01 To which item it meets paragraph 53
Statement
1.Date of occurrence of the event:2022/07/01
2.Company name:Medigen Vaccine Biologics Corp.
3.Relationship to the Company (please enter "head office" or
  "subsidiaries"):head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:
Pursuant to "Regulations Governing the Offering and Issuance of Securities
by Securities Issuers", hereby announcing.
6.Countermeasures:None
7.Any other matters that need to be specified:
(1)The Company issued 7,000,000 shares at NTD 220 per share for the cash
   capital increase; The total amount of NTD 1,540,000,000 has been fully
   collected.
(2)Reference date of cash capital increase:2022/7/1
(3)Expected listing date:2022/7/6

Company analysis

Earlier from Medigen Vaccine Biologics

All Medigen Vaccine Biologics news releases